IL-22 from dermal CD4+ T cells is highly expressed in lesional skin of psoriasis patients, and peripheral blood levels of IL-22 correlate strongly with disease activity, although these blood levels do not predict response to therapy (12). The gene discussed is IL22; the disease is psoriasis.